Neuland Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve the unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026

October 22, 2026 BSE Limited The National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, Exchange Plaza, 25th Floor, Dalal Street, Bandra Kurla Complex Mumbai – 400 001 Bandra (E), Mumbai – 400 001 Scrip Code: 524558 Scrip Code: NEULANDLAB; Series: EQ Dear Sir/Madam, Sub: Notice of Board Meeting Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of Board of Directors of the Company is scheduled to be held on Tuesday, November 3, 2026, inter-alia, to approve and take on record the unaudited financial results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026. In continuation to our letter dated September 25, 2026, pursuant to the Company's Insider Trading Code, the trading window for dealing in the equity shares of the Company shall continue to remain closed from October 1, 2026 till 48 hours after the declaration of unaudited financial results of the Company for the quarter and half year ended September 30, 2026 to the stock exchanges. This is for your information and records. Yours sincerely, For Neuland Laboratories Limited Sarada Bhamidipati Company Secretary